Jul 24, 2026· Comment from National Association of Manufacturers· FDA-2018-N-3240-3318
The National Association of Manufacturers (NAM) appreciates the opportunity to submit the attached comments in response to FDA's evaluation of "List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act".